Literature DB >> 19579693

A natural pertactin deficient strain of Bordetella pertussis shows improved entry in human monocyte-derived dendritic cells.

Paola Stefanelli1, Cecilia Fazio, Giorgio Fedele, Fabiana Spensieri, Clara Maria Ausiello, Paola Mastrantonio.   

Abstract

The invasion and the immunomodulatory effect of a Bordetella pertussis natural deficient strain 00141(PRN-) on human dendritic cells (MDDC) and its in vivo infection ability in a mouse model were evaluated in comparison with the reference B. pertussis strain ATCC 97-97 (18323). The mutant was isolated from a case of pertussis which occurred in a 22-month-old infant with typical symptoms of the disease. The results showed that this natural B. pertussis PRN deficient strain presented higher invasion ability of human MDDC compared to the reference strain. This natural mutant similar to the B. pertussis reference strain had immunomodulatory properties, inducing maturation in the DC phenotype which resulted in the acquisition of potent T cell-activating properties and down-regulated IL-12 production, and secretion of IL-10. The ability of PRN- strain to infect the lungs of CD1 mice was comparable to the reference strain and no difference was observed in the kinetics of clearance. Overall, these results show that the enhanced ability of the PRN- strain to invade/infect MDCC suggest that the PRN antigen may play a role in survival of the microorganism in the host.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19579693

Source DB:  PubMed          Journal:  New Microbiol        ISSN: 1121-7138            Impact factor:   2.479


  11 in total

1.  Pulsed-field gel electrophoresis analysis of Bordetella pertussis isolates circulating in Europe from 1998 to 2009.

Authors:  Abdolreza Advani; Hans O Hallander; Tine Dalby; Karen Angeliki Krogfelt; Nicole Guiso; Elisabeth Njamkepo; Carl Heinz Wirsing von Könnig; Marion Riffelmann; Frits R Mooi; Per Sandven; Anna Lutynska; Norman K Fry; Jussi Mertsola; Qiushui He
Journal:  J Clin Microbiol       Date:  2012-11-21       Impact factor: 5.948

2.  Appearance of Bordetella pertussis strains not expressing the vaccine antigen pertactin in Finland.

Authors:  Alex-Mikael Barkoff; Jussi Mertsola; Sophie Guillot; Nicole Guiso; Guy Berbers; Qiushui He
Journal:  Clin Vaccine Immunol       Date:  2012-08-22

3.  Bordetella pertussis proteins dominating the major histocompatibility complex class II-presented epitope repertoire in human monocyte-derived dendritic cells.

Authors:  Rachel M Stenger; Hugo D Meiring; Betsy Kuipers; Martien Poelen; Jacqueline A M van Gaans-van den Brink; Claire J P Boog; Ad P J M de Jong; Cécile A C M van Els
Journal:  Clin Vaccine Immunol       Date:  2014-03-05

4.  Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States.

Authors:  L C Pawloski; A M Queenan; P K Cassiday; A S Lynch; M J Harrison; W Shang; M M Williams; K E Bowden; B Burgos-Rivera; X Qin; N Messonnier; M L Tondella
Journal:  Clin Vaccine Immunol       Date:  2013-11-20

5.  Studies on Prn variation in the mouse model and comparison with epidemiological data.

Authors:  Marjolein van Gent; Inge H M van Loo; Kees J Heuvelman; Albert J de Neeling; Peter Teunis; Frits R Mooi
Journal:  PLoS One       Date:  2011-03-25       Impact factor: 3.240

6.  Prevalence and genetic characterization of pertactin-deficient Bordetella pertussis in Japan.

Authors:  Nao Otsuka; Hyun-Ja Han; Hiromi Toyoizumi-Ajisaka; Yukitsugu Nakamura; Yoshichika Arakawa; Keigo Shibayama; Kazunari Kamachi
Journal:  PLoS One       Date:  2012-02-14       Impact factor: 3.240

7.  Pertactin-deficient Bordetella pertussis isolates: evidence of increased circulation in Europe, 1998 to 2015.

Authors:  Alex-Mikael Barkoff; Jussi Mertsola; Denis Pierard; Tine Dalby; Silje Vermedal Hoegh; Sophie Guillot; Paola Stefanelli; Marjolein van Gent; Guy Berbers; Didrik Vestrheim; Margrethe Greve-Isdahl; Lena Wehlin; Margaretha Ljungman; Norman K Fry; Kevin Markey; Qiushui He
Journal:  Euro Surveill       Date:  2019-02

8.  New Data on Vaccine Antigen Deficient Bordetella pertussis Isolates.

Authors:  Valérie Bouchez; Nicolas Hegerle; Francesco Strati; Elisabeth Njamkepo; Nicole Guiso
Journal:  Vaccines (Basel)       Date:  2015-09-14

9.  Bordetella pertussis pertactin knock-out strains reveal immunomodulatory properties of this virulence factor.

Authors:  Elise Sofie Hovingh; Rob Mariman; Luis Solans; Daniëlle Hijdra; Hendrik-Jan Hamstra; Ilse Jongerius; Marjolein van Gent; Frits Mooi; Camille Locht; Elena Pinelli
Journal:  Emerg Microbes Infect       Date:  2018-03-21       Impact factor: 7.163

10.  Naturally circulating pertactin-deficient Bordetella pertussis strains induce distinct gene expression and inflammatory signatures in human dendritic cells.

Authors:  Michiel M Kroes; Alberto Miranda-Bedate; Elise S Hovingh; Ronald Jacobi; Corrie Schot; Elder Pupo; René H M Raeven; Arno A J van der Ark; Jos P M van Putten; Jelle de Wit; Rob Mariman; Elena Pinelli
Journal:  Emerg Microbes Infect       Date:  2021-12       Impact factor: 7.163

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.